UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties : relevance for its mode of action in Alzheimer's disease and geriatric depression

Molecular psychiatry, 2000-11, Vol.5 (6), p.616-632

2000

Volltextzugriff (PDF)

Abnormalities of the corpus callosum in first episode, treatment naive schizophrenia

Journal of neurology, neurosurgery and psychiatry, 2002-06, Vol.72 (6), p.757-760

2002

Volltextzugriff (PDF)

Increased cerebrospinal fluid glutamine levels in depressed patients

Biological psychiatry (1969), 2000-04, Vol.47 (7), p.586-593

2000

Volltextzugriff (PDF)

Decreased Caudate Volume in Neuroleptic-Naive Psychotic Patients

The American journal of psychiatry, 1998-06, Vol.155 (6), p.774-778

1998

Volltextzugriff (PDF)

Is Schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited

Journal of psychiatric research, 1994-05, Vol.28 (3), p.239-265

1994

Volltextzugriff (PDF)

A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease

Neurology, 1996-09, Vol.47 (3), p.705-711

1996

Volltextzugriff (PDF)

Superior temporal gyrus and the course of early schizophrenia: Progressive, static, or reversible?

Journal of psychiatric research, 1998-05, Vol.32 (3), p.161-167

1998

Volltextzugriff (PDF)

Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation

The journal of histochemistry and cytochemistry, 1989-08, Vol.37 (8), p.1273-1281

1989

Volltextzugriff (PDF)

Development of small molecule probes for the Beta-amyloid protein of Alzheimer's Disease

Neurobiology of aging, 1994-11, Vol.15 (6), p.691-698

1994

Volltextzugriff (PDF)

Brain membrane phospholipid alterations in Alzheimer's disease

Neurochemical research, 2001-07, Vol.26 (7), p.771-782

2001

Volltextzugriff (PDF)

Metabolic alterations in postmortem Alzheimer’s disease brain are exaggerated by Apo-E4

Neurobiology of aging, 1998-11, Vol.19 (6), p.511-515

1998

Volltextzugriff (PDF)

Chrysamine-G binding to Alzheimer and control brain: Autopsy study of a new amyloid probe

Neurobiology of aging, 1995-07, Vol.16 (4), p.541-548

1995

Volltextzugriff (PDF)

Landmark-based morphometric analysis of first-episode schizophrenia

Biological psychiatry (1969), 1999-05, Vol.45 (10), p.1321-1328

1999

Volltextzugriff (PDF)

Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease

Neurobiology of aging, 1995, Vol.16 (1), p.1-4

1995

Volltextzugriff (PDF)

Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study

Neurobiology of aging, 1994, Vol.15 (1), p.117-132

1994

Volltextzugriff (PDF)

Molecular insights into neurodevelopmental and neurodegenerative diseases

Brain research bulletin, 2000-11, Vol.53 (4), p.455-469

2000

Volltextzugriff (PDF)

N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study

Neurology, 1992-08, Vol.42 (8), p.1578-1578

1992

Volltextzugriff (PDF)

Stability of CSF metabolites measured by proton NMR

Journal of Neural Transmission, 2000-01, Vol.107 (7), p.843-848

2000

Volltextzugriff (PDF)

Alzheimer's Disease: Soluble Oligomeric A beta (1-40) Peptide in Membrane Mimic Environment from Solution NMR and Circular Dichroism Studies

Neurochemical research, 2004-12, Vol.29 (12), p.2267-2272

2004

Volltextzugriff (PDF)

Elevated Phosphocholine and Phosphatidylcholine Following Rat Entorhinal Cortex Lesions

Neurobiology of aging, 1997-05, Vol.18 (3), p.305-308

1997

Volltextzugriff (PDF)

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings—part II

Biological Psychiatry, 2000-09, Vol.48 (5), p.369-380

2000

Volltextzugriff (PDF)

CHEMICAL AND PHYSIOLOGIC BRAIN IMAGING IN SCHIZOPHRENIA

The Psychiatric clinics of North America, 1998-03, Vol.21 (1), p.93-122

1998

Volltextzugriff (PDF)

Magnetic Resonance Spectroscopic Changes in Alzheimer's Disease

Annals of the New York Academy of Sciences, 1997-09, Vol.826 (1), p.282-306

1997

Volltextzugriff (PDF)

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings–part I

Biological Psychiatry, 2000-09, Vol.48 (5), p.357-368

2000

Volltextzugriff (PDF)

Two simple methods for quantifying low-affinity dye-substrate binding

The journal of histochemistry and cytochemistry, 1989-08, Vol.37 (8), p.1293-1297

1989

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(133)

Publikationsform

Artikel
(153)
Buchkapitel
(1)

Sprache

Englisch
(154)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(86)
Science & Technology
(85)
Life Sciences & Biomedicine
(81)
Biological And Medical Sciences
(68)
Medical Sciences
(56)
Neurosciences & Neurology
(54)
Magnetic Resonance Spectroscopy
(50)
Neurosciences
(49)
Male
(48)
Female
(43)
Animals
(29)
Alzheimer Disease - Metabolism
(27)
Brain - Metabolism
(27)
Psychology. Psychoanalysis. Psychiatry
(27)
Alzheimer's Disease
(26)
Neurology
(26)
Psychiatry
(26)
Adult
(25)
Psychopathology. Psychiatry
(25)
Phospholipids - Metabolism
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties : relevance for its mode of action in Alzheimer's disease and geriatric depression

Abnormalities of the corpus callosum in first episode, treatment naive schizophrenia

Increased cerebrospinal fluid glutamine levels in depressed patients

Decreased Caudate Volume in Neuroleptic-Naive Psychotic Patients

Is Schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited

A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease

Superior temporal gyrus and the course of early schizophrenia: Progressive, static, or reversible?

Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation

Development of small molecule probes for the Beta-amyloid protein of Alzheimer's Disease

Brain membrane phospholipid alterations in Alzheimer's disease

Metabolic alterations in postmortem Alzheimer’s disease brain are exaggerated by Apo-E4

Chrysamine-G binding to Alzheimer and control brain: Autopsy study of a new amyloid probe

Landmark-based morphometric analysis of first-episode schizophrenia

Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease

Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study

Molecular insights into neurodevelopmental and neurodegenerative diseases

N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study

Stability of CSF metabolites measured by proton NMR

Alzheimer's Disease: Soluble Oligomeric A beta (1-40) Peptide in Membrane Mimic Environment from Solution NMR and Circular Dichroism Studies

Elevated Phosphocholine and Phosphatidylcholine Following Rat Entorhinal Cortex Lesions

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings—part II

CHEMICAL AND PHYSIOLOGIC BRAIN IMAGING IN SCHIZOPHRENIA

Magnetic Resonance Spectroscopic Changes in Alzheimer's Disease

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings–part I

Two simple methods for quantifying low-affinity dye-substrate binding

Suchergebnisse filtern